Genmab — December 2020
-
Dollarens deroute rammer mange aktier på den danske børs, her i blandt også Genmabs bundlinje....
-
Om amivantamab-filingen sagde Winkel på CC: "If this occurs, it will be the first investigational therapy using our proprietary DuoBody technology platform submitted for approval in the U.S., a major milestone for this technology and for Genmab." Og nu siger han ikke en lyd. Mærkeligt.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
